Drug research

LX9211

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Efficacy and Safety of LX9211 in Participants With Postherpetic NeuralgiaNCT04662281	Lexicon Pharmaceuticals	Phase 2	Completed	2022-11-18Actual
Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic PainNCT04455633	Lexicon Pharmaceuticals	Phase 2	Completed	2022-05-23Actual

Lexicon PharmaceuticalsCompletedPrimary completion: 2022-11-18 · Actual

Trial details

Lexicon PharmaceuticalsCompletedPrimary completion: 2022-05-23 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.